<
SYNJARDY (EMPAGLIFLOZIN/METFORMIN)5MG/1000MG TABLETS
Synjardy combines two antihyperglycaemic medicinal products with complementary mechanisms of action to improve glycaemic control in patients with type 2 diabetes: empagliflozin, an inhibitor of sodium-glucose co-transporter 2 (SGLT2), and metformin hydrochloride, a member of the biguanide class.
KES 9,831.00
(Inclusive of all taxes)
-
Compare
-
Share:
-
No Warranty
-
COD Avilable
-
Non Returnable
-
Non cancelable
SYNJARDY (EMPAGLIFLOZIN/METFORMIN)5MG/1000MG TABLETS
No FAQs Found
Related Products
